Ofer Haviv | executive |
Yaron Eldad | executive |
Ryan Mayer | analyst |
Brian Wright | analyst |
Benjamin Haynor | analyst |
Nir Arbel | executive |
Ladies and gentlemen, thank you for standing by. Welcome to Evogene's Third Quarter 2023 Results Conference Call. [Operator Instructions] As a reminder, this conference is being recorded, November 15, 2023.Before we begin, I would like to caution that certain statements made during this earnings conference call by Evogene's management will constitute forward-looking statements that relate to future events, risks and uncertainties regarding business strategy, operations and future performance and results of Evogene. I encourage you to review Evogene's filings with the U.S. Securities and Exchange Commission and read the note regarding forward-looking statements in today's earnings release, which states that statements made in the earnings release and in a similar way, on this earnings conference call that are not historical facts, may be deemed forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.